Welcome
Ordering and Supplemental Information
Proficiency Testing/EQA
Quality Management Tools
Learning
Publications

Proficiency Testing/EQA / Genetics and Molecular Pathology /
Molecular Oncology-Hematologic

Please log in to determine if you are eligible to purchase PT Programs.
MEASURABLE (MINIMAL) RESIDUAL DISEASE - MRD
MRD
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte Challenges per Shipment Number of Shipments
BCR::ABL1 p210 3 Two shipments per year

Program Information

  • Three RNA specimens in sterile water
  • For laboratories diagnosing and monitoring leukemia tumor burden by measuring the quantity of BCR::ABL1 fusion transcripts
  • Ships on dry ice

Shipping Schedule

  • Shipment A: April 15
  • Shipment B: September 30






Guest

Log in/Register

Customers Who Bought This Item Also Bought
B-ALL MEASURABLE (MINIMAL) RESIDUAL DISEASE
VIEW DETAILS >